Cargando…
Involvement of the Catecholamine Pathway in Glioblastoma Development
Glioblastoma (GBM) is the most aggressive tumor of the central nervous system (CNS). The standard of care improves the overall survival of patients only by a few months. Explorations of new therapeutic targets related to molecular properties of the tumor are under way. Even though neurotransmitters...
Autores principales: | Kraboth, Zoltán, Kajtár, Bela, Gálik, Bence, Gyenesei, Attila, Miseta, Attila, Kalman, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998903/ https://www.ncbi.nlm.nih.gov/pubmed/33806345 http://dx.doi.org/10.3390/cells10030549 |
Ejemplares similares
-
Epigenetic Suppression of the IL-7 Pathway in Progressive Glioblastoma
por: Tompa, Marton, et al.
Publicado: (2022) -
DNA CpG methylation in sequential glioblastoma specimens
por: Kraboth, Zoltan, et al.
Publicado: (2020) -
Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies
por: Kraboth, Zoltan, et al.
Publicado: (2019) -
ß-Adrenoreceptors in Human Cancers
por: Kraboth, Zoltan, et al.
Publicado: (2023) -
Physical exercise induces mental flow related to catecholamine levels in noncompetitive, but not competitive conditions in men
por: Karsai, István, et al.
Publicado: (2023)